Pancreatic Islet Cells in Preobese Yellow Avy/- Mice: Relation to Adult Hyperinsulinemia and Obesity

Proceedings of the Society for Experimental Biology and Medicine

Volumn 206, Issue 2, 1994, Pages 145-151

  Warbritton, Alan ^a   Gill, Anne M ^b   Yen, Terence T ^b,c   Bucci, Thomas ^a   Wolff, George L ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; INSULIN;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; FEMALE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SYNTHESIS; LIPOGENESIS; MALE; MOUSE; NEWBORN; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL;

AGE FACTORS; ANIMAL; BODY WEIGHT; FEMALE; GLUCAGON; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; OBESITY; ORGAN WEIGHT; PANCREAS;

EID: 0028340217     PISSN: 00379727     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/00379727-206-43733     Document Type: Article

References (16)

1. vy/- mice: Ectopic expression of the agouti gene. FASEB J (in press).
2. so) mutations. J Hered 69:295–298, 1978.
3. vy/A) (BALB/c x VY)F-1 hybrid mice by hyperglycemic peptide(s) from human pituitary glands. Endocrinology 113:2097–2105, 1983.
4. Wolff GL, Medina D, Umholtz RL. Manifestation of hyperplastic alveolar nodules and mammary tumors in “viable yellow” and non-yellow mice. J Natl Cancer Inst 63:781–785, 1979.
5. Wolff GL, Gaylor DW, Frith CH, Suber RL. Controlled genetic variation in a subchronic toxicity assay: Susceptibility to induction of bladder hyperplasia in mice by 2-acetylaminofluorene. J Toxicol Environ Health 12:255–265, 1983.
6. Wolff GL. Pancreatic islet hyperplasia and elevated insulin levels in preobese yellow (BALB/c x VY)F-1 hybrid mice. NCTR Technical Report for Experiment 6208, 1987.
7. Sheehan DC, Hrapchak BB. Theory and Practice of Histotechnology (2nd ed) St. Louis: C. V. Mosby, pp 272–273, 1980.
8. Dore BA, Grogan WM, Madge GE, Webb SR. Biphasic development of the postnatal mouse pancreas. Biol Neonate 40:209–217, 1981.
9. Wolff GL, Greenman DL, Frigeri LG, Morrissey RL, Suber RL, Felton RP. Diabetogenic response to streptozotocin varies among obese yellow and among lean agouti (BALB/c × VY)F-1 hybrid mice. Proc Soc Exp Biol Med 193:155–163, 1990.
10. Shimizu H, Shargill NS, Bray GA, Yen TT, Gesellchen PD. Effects of MSH on food intake, body weight and coat color of the yellow obese mouse. Life Sci 45:543–552, 1989.
11. Dunbar JC, Ergene E, Barraco RA. Neuropeptide-Y stimulation of insulin secretion is mediated via the nucleus tractus solerius. Horm Metab Res 24:103–105, 1992.
12. Jeanrenaud B. An hypothesis on the aetiology of obesity: Dysfunction of the central nervous system as a primary cause. Diabetologia 28:502–513, 1985.
13. Rohner-Jeanrenaud F, Hochstrasser AC, Jeanrenaud B. Hyper-insulinemia of preobese and obese falfa rats is partly vagus nerve mediated. Am J Physiol 244:E317–E322, 1983.
14. Rohner-Jeanrenaud F, Jeanrenaud B. Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic pre-obesity. Endocrinology 116:830–834, 1985.
15. Bultman, SJ, Michaud EJ, Woychik RP. Molecular characterization of the mouse agouti locus. Cell 71:1195–1204, 1992.
16. Miller MW, Duhl DMJ, Vrieling H, Cordes SP, Ollmann MM, Winkes BM, Barsh GS. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Gen Dev 7:454–467, 1993.